Related Experiment Video
Updated: May 26, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial catheter ablation and ischemic stroke
Karl Georg Haeusler1, Paulus Kirchhof, Matthias Endres
1Department of Neurology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. georg.haeusler@charite.de
Insights
Left atrial catheter ablation (LACA) can treat atrial fibrillation but carries a 0.5-1% stroke risk. LACA may also cause microemboli, leading to cognitive issues, necessitating further research on stroke prevention.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Medical Technology
Background:
- Left atrial catheter ablation (LACA) is a standard treatment for drug-refractory atrial fibrillation (AF).
- LACA aims to restore sinus rhythm, potentially preventing AF-related strokes, though randomized trial evidence is lacking.
- Existing data suggest LACA patients often have low baseline stroke risk, contrasting with the procedure's inherent risk.
Purpose of the Study:
- To review current knowledge on LACA and its association with procedure-related ischemic stroke.
- To highlight uncertainties regarding LACA's impact on stroke risk and cognitive function.
- To emphasize the need for further research into stroke risk factors and anticoagulation strategies post-LACA.
Main Methods:
- Review of existing literature on left atrial catheter ablation and ischemic stroke.
- Analysis of stroke risk associated with LACA procedures.
- Discussion of cerebral microemboli, MRI-detected lesions, and cognitive dysfunction following LACA.
Main Results:
- LACA carries a procedure-related ischemic stroke risk of approximately 0.5% to 1%.
- Cerebral microemboli and MRI-detectable ischemic lesions are potential consequences of LACA, linked to cognitive deficits.
- Recurrent AF post-LACA can lead to strokes, particularly if anticoagulation is stopped.
Conclusions:
- While LACA treats AF, it introduces a significant procedural stroke risk.
- LACA-induced cerebral lesions may contribute to cognitive impairment.
- Prospective trials are essential to identify stroke risk factors and optimize post-LACA anticoagulation.
Abstract:
Left atrial catheter ablation (LACA) has become an established therapy to abolish drug-refractory symptomatic paroxysmal and persistent atrial fibrillation. Restoring sinus rhythm by LACA may help to prevent atrial fibrillation-related strokes, but presently there is no evidence from randomized clinical trials to support this notion. This review summarizes the current knowledge and uncertainties regarding LACA and procedure-related ischemic stroke. In fact, most patients who undergo LACA have a rather low annual stroke risk even when left untreated, whereas LACA imposes a risk of procedure-related stroke of ≈0.5% to 1%. In addition, LACA may cause cerebral microemboli, resulting in ischemic lesions. These cerebral lesions, detectable by high-resolution MRI, could contribute to neuropsychological deficits and cognitive dysfunction. Furthermore, recurrent atrial fibrillaton episodes can be detected up to years after LACA and might cause ischemic strokes, especially in those patients in whom therapeutic anticoagulation was discontinued. Further prospective multicenter trials are needed to identify procedure-dependent risk factors for stroke and to optimize postprocedural anticoagulation management.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization

